Prodrug of 5-Fluorouracil
(5-FU) (Cat. No. 3257). Selectively activated in tumor cells by thymidine phosphorylase; inhibits DNA synthesis upon conversion to 5-FU. Orally available.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
The design and synthesis of a new tumor-selective fluoropyrimidine carbamate, capecitabine.
Shimma et al.
Metabolism of capecitabine, an oral fluorouracil prodrug: 19F NMR studies in animal models and human urine.
Desmoulin et al.
Drug Metab.Dispos., 2002;30:1221
Cell cycle phase specificity of antitumor agents.
Bhuyan et al.
Cancer Res., 1972;32:398